Word: genericizing
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...sold well, but few like-minded acts shared their success. This year it's Moby, and perhaps acts like Alice Deejay and others will follow. Maybe this time rave culture is here to stay...or maybe it'll slip safely back into the underground with alternative rock. With horrifyingly generic teen-pop acts blaring out from MTV's Total Request Live day in and day out, it's a wonder more kids haven't turned to drugs to escape the awful racket. Sure, a fair amount of electronica is wordless wallpaper, but slip on Moby's soulful, cerebral Play...
...West that he and Chan inhabit is more generic than authentic--come to think of it, a lot like the B-picture West in which the real John Wayne toiled through his early years. It's the kind of place where the subsidiary gunmen have no real motives--other than bad breeding--for their depredations, where barroom brawls blow up for no good reason and where plains, mountains and deserts are mixed without any particular geo-logic. This, of course, frees the director, Tom Dey, to play fast and loose with other kinds of logic. In his West, horses...
Three years ago in North Carolina, DuPont helped ram through the legislature a bill requiring doctor's approval for the substitution of generics like Barr's warfarin. "We are only concerned about patient safety," says DuPont spokesman Thomas Barry. Some physicians support DuPont's position because they say warfarin is a tricky drug and doses must be carefully calibrated. The implication is that the brand names do a better job of that. But the FDA says the generic version is safe and has admonished DuPont more than once for stoking false fears in its promotion of Coumadin...
DuPont isn't the only company throwing tacks in the path of its generic rivals. Just last week Novartis, maker of the blockbuster anti-rejection drug Neoral, for organ-transplant patients, failed to get a Massachusetts state drug board to limit sales of Neoral's equivalent, generic cyclosporine. Ohio's senate, egged on by Novartis, has held 11 hearings in two years on this issue. "They have been bloody dogged on this," says R.J. Tesi, an executive with generic cyclosporine maker SangStat Medical Corp. He points out that patients spend $5,000 or more on Neoral yearly, while the generic...
...generic-drug makers feel as if they're playing a game of 50-state Whack-a-Mole, never knowing where another amendment or rule pushed by their rivals is going to pop up. Take Illinois: last year Barr and its allies persuaded legislators to dissolve a state panel that had delayed marketing of some FDA-approved generics, but Governor George Ryan vetoed the bill. Still, all sides worked out a compromise to give immediate approval to most generics. Barr's lobbyists relaxed. Too soon, it turns out. A month ago, an amendment was quietly tacked onto a new bill...